Cargando…
Prognostic related gene index for predicting survival and immunotherapeutic effect of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is the most common malignant liver tumor. It is an aggressive disease with high mortality rate. In this study, we investigated a new prognosis-related gene index (PRGI) that can predict the survival and efficacy of immunotherapy in patients with HCC. RNA-seq data and c...
Autores principales: | Du, Zhongxiang, Zhang, Qi, Yang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627638/ https://www.ncbi.nlm.nih.gov/pubmed/37933057 http://dx.doi.org/10.1097/MD.0000000000035820 |
Ejemplares similares
-
CNN3 in glioma: The prognostic factor and a potential immunotherapeutic target
por: Xu, Hao, et al.
Publicado: (2021) -
Prognostic value of immunoscore to identify mortality outcomes in adults with HBV-related primary hepatocellular carcinoma
por: Yao, Qinwei, et al.
Publicado: (2017) -
Development and validation of 9-long Non-coding RNA signature to predicting survival in hepatocellular carcinoma
por: Deng, Benyuan, et al.
Publicado: (2020) -
High expression of HILPDA is an adverse prognostic prognostic factor in hepatocellular carcinoma
por: Wang, Xiao, et al.
Publicado: (2023) -
Study on the gene signature related to immune microenvironment on viral and nonviral infections of hepatocellular carcinoma
por: Qian, Hong, et al.
Publicado: (2021)